These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31125673)

  • 1. Rate and rhythm therapy in patients with atrial fibrillation and the risk of pacing and bradyarrhythmia.
    Dalgaard F; Pallisgaard JL; Lindhardt TB; Torp-Pedersen C; Gislason GH; Ruwald MH
    Heart Rhythm; 2019 Sep; 16(9):1348-1356. PubMed ID: 31125673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate or Rhythm Control in Older Atrial Fibrillation Patients: Risk of Fall-Related Injuries and Syncope.
    Dalgaard F; Pallisgaard JL; Numé AK; Lindhardt TB; Gislason GH; Torp-Pedersen C; Ruwald MH
    J Am Geriatr Soc; 2019 Oct; 67(10):2023-2030. PubMed ID: 31339174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction.
    Essebag V; Hadjis T; Platt RW; Pilote L
    J Am Coll Cardiol; 2003 Jan; 41(2):249-54. PubMed ID: 12535818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between serum potassium levels and short-term mortality in patients with atrial fibrillation or flutter co-treated with diuretics and rate- or rhythm-controlling drugs.
    Hagengaard L; Søgaard P; Espersen M; Sessa M; Lund PE; Krogager ML; Torp-Pedersen C; Kragholm KH; Polcwiartek C
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):137-144. PubMed ID: 31263883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses.
    Saksena S; Slee A; Waldo AL; Freemantle N; Reynolds M; Rosenberg Y; Rathod S; Grant S; Thomas E; Wyse DG
    J Am Coll Cardiol; 2011 Nov; 58(19):1975-85. PubMed ID: 22032709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone after surgical ablation for atrial fibrillation: Is it really necessary? A prospective randomized controlled trial.
    Ad N; Holmes SD; Shuman DJ; Pritchard G; Miller CE
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):798-803. PubMed ID: 26253874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality risk of long-term amiodarone therapy for atrial fibrillation patients without structural heart disease.
    Qin D; Leef G; Alam MB; Rattan R; Munir MB; Patel D; Khattak F; Adelstein E; Jain SK; Saba S
    Cardiol J; 2015; 22(6):622-9. PubMed ID: 26412606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter.
    Hauser TH; Pinto DS; Josephson ME; Zimetbaum P
    Am J Cardiol; 2003 Jun; 91(12):1437-41. PubMed ID: 12804730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Comparison of Classes IC and III Antiarrhythmic Drugs as an Initial Rhythm Control Strategy in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
    Kipp R; Askari M; Fan J; Field ME; Turakhia MP
    JACC Clin Electrophysiol; 2019 Feb; 5(2):231-241. PubMed ID: 30784696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of hospitalization rates among younger atrial fibrillation patients receiving different antiarrhythmic drugs.
    Allen LaPointe NM; Dai D; Thomas L; Piccini JP; Peterson ED; Al-Khatib SM
    Circ Cardiovasc Qual Outcomes; 2015 May; 8(3):292-300. PubMed ID: 25829248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of antiarrhythmic drugs to maintain sinus rhythm after catheter ablation for atrial fibrillation: a meta-analysis.
    Xu X; Alida CT; Yu B
    Cardiovasc Ther; 2015 Aug; 33(4):242-6. PubMed ID: 26031448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.
    Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Piccione G; Di Giovanni N; Colletti A; Pensabene O; Lisi F; Vasquez L; Grammatico A; Boriani G;
    Am Heart J; 2008 Jan; 155(1):100-7, 107.e1. PubMed ID: 18082498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Antiarrhythmic Drug Therapy With Syncope and Pacemaker Implantation in Patients With Atrial Fibrillation.
    Kim YG; Lee HS; Kim H; Kim M; Jeong JH; Choi YY; Shim J; Choi JI; Kim YH
    J Am Coll Cardiol; 2024 Mar; 83(11):1027-1038. PubMed ID: 38479951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guideline-Concordant Antiarrhythmic Drug Use in the Get With The Guidelines-Atrial Fibrillation Registry.
    Field ME; Holmes DN; Page RL; Fonarow GC; Matsouaka RA; Turakhia MP; Lewis WR; Piccini JP;
    Circ Arrhythm Electrophysiol; 2021 Feb; 14(2):e008961. PubMed ID: 33419385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class 1C antiarrhythmic drugs in atrial fibrillation and coronary artery disease.
    Pantlin PG; Bober RM; Bernard ML; Khatib S; Polin GM; Rogers PA; Morin DP
    J Cardiovasc Electrophysiol; 2020 Mar; 31(3):607-611. PubMed ID: 31912933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early outcome of initiating amiodarone for atrial fibrillation in advanced heart failure.
    Weinfeld MS; Drazner MH; Stevenson WG; Stevenson LW
    J Heart Lung Transplant; 2000 Jul; 19(7):638-43. PubMed ID: 10930812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic therapy and risk of death in patients with atrial fibrillation: a nationwide study.
    Andersen SS; Hansen ML; Gislason GH; Schramm TK; Folke F; Fosbøl E; Abildstrøm SZ; Madsen M; Køber L; Torp-Pedersen C
    Europace; 2009 Jul; 11(7):886-91. PubMed ID: 19443433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association Between the Use of Antiarrhythmic Drugs in Non-Valvular Atrial Fibrillation and Patient Prognosis Using Data from the China Atrial Fibrillation (China-AF) Registry.
    Hou XX; Du X; Zheng D; Li YM; He L; Li XX; Dong JZ
    Med Sci Monit; 2019 Jun; 25():4856-4868. PubMed ID: 31256190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of amiodarone use and outcomes in clinical practice for atrial fibrillation.
    Pokorney SD; Holmes DN; Shrader P; Thomas L; Fonarow GC; Mahaffey KW; Gersh BJ; Kowey PR; Naccarelli GV; Freeman JV; Singer DE; Washam JB; Peterson ED; Piccini JP; Reiffel JA
    Am Heart J; 2020 Feb; 220():145-154. PubMed ID: 31812756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of patients with atrial fibrillation and dronedarone's place in therapy.
    Cohen M; Boiangiu C
    Adv Ther; 2011 Dec; 28(12):1059-77. PubMed ID: 22170292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.